Scripps Research Institute

Return to Grants

Total Awards:
29
Award Value:
$62,068,929
Institution type:
Not for profit
Short Name:
Scripps Research

Awards to the Institution

Program Type Investigator Grant Title Award Value
Foundation – Discovery Stage Research Projects Xin Jin Functional genomics to study cellular convergence across ASD risk genes in neurodevelopment $1,575,001
Research Training Grant Peter G. Schultz Training Scholars in Regenerative Medicine and Stem Cell Research $5,305,095
Discovery Research Projects Stuart A Lipton M.D., Ph.D. Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage $150,000
Quest – Discovery Stage Research Projects Stuart A Lipton M.D., Ph.D. Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG) $1,658,123
Quest – Discovery Stage Research Projects Dr Michael J Bollong Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS) $1,244,160
Quest – Discovery Stage Research Projects Luke L Lairson Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs $1,554,126
Quest – Discovery Stage Research Projects Stuart A Lipton M.D., Ph.D. Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs $1,827,576
Quest – Discovery Stage Research Projects Dr. Jeanne F Loring Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons $2,299,786
Tools and Technologies III Dr. Jeanne F Loring User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery $1,728,390
Conference Dr. Jeanne F Loring World Stem Cell Summit $30,000
Creativity Awards James R Williamson Stem Cell Summer Academy: Creating the Next Generation of Scientists $205,122
Early Translational III Peter G. Schultz Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $2,559,333
Training Grant I-2 Peter G. Schultz Training Grant I $1,021,395
Research Training II Dr. Ulrich Mueller Training Stem Cell Researchers at the Chemistry-Biology Interface $3,697,326
Basic Biology III Dr. Joel M Gottesfeld Triplet Repeat Instability in Human iPSCs $1,705,494
Basic Biology III Dr. Kristin K Baldwin Dr. Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing $1,705,500
Early Translational II Peter G. Schultz Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,047,249
New Faculty I Dr. Kristin K Baldwin Dr. Generating pluripotent cell lines from neurons. $2,786,560
New Faculty I Dr. Sheng Ding Dr. Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,393,876
Early Translational I Dr. Martin Friedlander Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,806,321
Early Translational I Dr. Jeanne F Loring Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $5,830,771
Transplantation Immunology Dr. Nicholas R.J. Gascoigne Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance $1,705,554
Transplantation Immunology Dr. Jeanne F Loring Thymus based tolerance to stem cell therapies $1,108,921
Tools and Technologies I Dr. Jeanne F Loring The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells $1,133,552
Tools and Technologies I Dr. Carlos F. Barbas Dr. Development of a novel technology for precise, efficient, and safe genetic modification of stem cells $1,138,548
Shared Labs Sheng Ding PhD TSRI Center for hESC Research $1,440,164
Shared Labs Dr. Jeanne F Loring TSRI Center for hESC Research $3,725,070
New Cell Lines Dr. Sheng Ding Dr. Derivation of New ICM-stage hESCs $936,973
SEED Grant Peter G. Schultz A Chemical Approach to Stem Cell Biology $748,944
Total:
$62,068,929.01